Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Sucralfate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sucralfate 1g/5ml oral suspension sugar free
0103030S0AAADAD
|
Sucralfate (Systemic) | Sucralfate | Gastro-Intestinal System | 3,711 |
|
Sucralfate 1g tablets
0103030S0AAAAAA
|
Sucralfate (Systemic) | Sucralfate | Gastro-Intestinal System | 2,936 |
|
Sucralfate 2g/20ml enema
0107010S0AAAKAK
|
Sucralfate (Rectal) | Sucralfate | Gastro-Intestinal System | 93 |
|
Sucralfate 1g/5ml oral suspension
0103030S0AAAEAE
|
Sucralfate (Systemic) | Sucralfate | Gastro-Intestinal System | 90 |
|
Sucralfate 2g/50ml enema
0107010S0AAALAL
|
Sucralfate (Rectal) | Sucralfate | Gastro-Intestinal System | 48 |
|
Sucralfate 250mg/5ml oral suspension
0103030S0AAACAC
|
Sucralfate (Systemic) | Sucralfate | Gastro-Intestinal System | 9 |
|
Sucralfate powder
1313080S0AAADAD
|
Sucralfate (Topical) | Sucralfate | Skin | 9 |
|
Sulcrate 1g tablets
0103030S0BCAAAA
|
Sulcrate | Sucralfate | Gastro-Intestinal System | 2 |
|
Antepsin 1g tablets
0103030S0BBAAAA
|
Antepsin | Sucralfate | Gastro-Intestinal System | No data available |
|
Antepsin 1g/5ml oral suspension
0103030S0BBABAD
|
Antepsin | Sucralfate | Gastro-Intestinal System | No data available |
|
Carafate 1g tablets
0103030S0BDAAAA
|
Carafate | Sucralfate | Gastro-Intestinal System | No data available |
|
Sucralfate 1g/30ml enema
0107010S0AAAIAI
|
Sucralfate (Rectal) | Sucralfate | Gastro-Intestinal System | No data available |
|
Sucralfate 4% in Emulsifying ointment
0107010S0AAAJAJ
|
Sucralfate (Rectal) | Sucralfate | Gastro-Intestinal System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.